Patents Assigned to Intervert Inc.
  • alpha toxoid vaccine
    Patent number: 8980283
    Abstract: The present invention describes vaccines that comprise C. perfringens Type alpha toxoids, antigenic fragments thereof, inactivated antigenic fragments of C. perfringens Type alpha toxins, or any combination thereof. The present invention further describes methods of using with these vaccines to protect animals against clostridial diseases. The present invention also describes methods of making these vaccines.
    Type: Grant
    Filed: April 17, 2006
    Date of Patent: March 17, 2015
    Assignee: Intervert Inc.
    Inventors: Huchappa Jayappa, Kevin O'Connell